Upregulation of BCL-2 has been closely related to aggressive traits in NPC including lymph node involvement, metastasis, recurrence, and poor survival rates in NPC patients [29, 89, 90, 92]. The gene discussed is BCL2; the disease is nasopharyngeal carcinoma.